Today: 23 January 2026
Subscribe
Browse Category

NASDAQ:QXO News 16 January 2026

QXO stock drops on $750 million share sale pricing and early Q4 snapshot

QXO stock drops on $750 million share sale pricing and early Q4 snapshot

New York, Jan 16, 2026, 3:35 PM EST — Regular session Shares of QXO Inc fell Friday following the announcement of a $750 million common-stock offering. The building-products distributor also released a brief preliminary snapshot of its fourth-quarter results. (QXO Investors) QXO’s current financing is crucial since the company has been raising funds to back acquisitions. Selling stock at a…
16 January 2026
·····

Stock Market Today

  • Johnson & Johnson and Merck: Two Healthcare Stocks to Hold for 20 Years
    January 23, 2026, 1:21 PM EST. Johnson & Johnson (JNJ) and Merck (MRK) stand out as durable picks for long-term investors, driven by strong healthcare franchises. Merck's oncology focus, led by its blockbuster cancer drug Keytruda, positions it for continued sales growth despite looming patent expiration in 2028. The company also expands with new approvals and formulations to sustain momentum. Johnson & Johnson benefits from a diversified portfolio across pharmaceuticals and medical devices, consistently delivering revenue and earnings, even amid challenges. Both stocks offer attractive dividend yields - Merck at 3.1% with nearly doubling payouts historically, and Johnson & Johnson at 2.35%. Their scale, innovation, and dividend track records make them solid candidates for wealth accumulation over two decades, despite short-term volatility.
Go toTop